Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.
Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Cell Carcinoma; Update of the Long-Term Tumor Control of a Randomized Clinical Trial
Speaker : Kanika Sood Sharma
Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer.
18F-FDG-PET/CT-based treatment planning for definitive (chemo) radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival
Moderator : Madhuri Shimpi
Prognostic role of pre-treatment magnetic resonance imaging (MRI) radiomic analysis in patients with squamous cell carcinoma of the head and neck (SCCHN).
Speaker : Abhishek Mahajan
Panel Discussion on new interventions in head and neck cancers
Moderator : Sarbani Laskar
Choosing right options to optimize outcomes in 1L RM SCCHN
Moderator : Kumar Prabhash
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma
Extracapsular Dissection Versus Partial Superficial Parotidectomy for the Treatment of Benign Parotid Tumours
The Diagnostic Role of Ultrasonography, Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography/Computed Tomography, and Real-Time Elastography in the Differentiation of Benign and Malignant Salivary Gland Tumors: A Meta-Analysis
Speaker : Abhishek Bansal
Prognostic markers in salivary gland cancer and their impact on survival
Speaker : Chandralekha Tampi
Panel Discussion on cancers of salivary gland
Comparing the Utility and Surgical Outcomes of Harmonic Focus Ultrasonic Scalpel With Ligasure Small Jaw Bipolar Device in Thyroidectomies: A Prospective Randomized Controlled Trial
Speaker : Swagnik Chakrabarti
Association Between TERT Promoter Mutations and Clinical Behaviors in Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis
A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis
Panel Discussion on Thyroid Cancers